TUMOR-NECROSIS-FACTOR PRODUCTION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA

被引：14

作者：

HAHN, T

KUSMINSKY, G

BASSOUS, L

BERREBI, A

机构：

[1] Hematology Unit and Pediatric Research Institute, Kaplan Hospital, Rehovot

来源：

LEUKEMIA & LYMPHOMA | 1991年 / 4卷 / 02期

关键词：

B-CLL; TNF; CYTOKINES;

D O I：

10.3109/10428199109068054

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tumor necrosis factor (TNF) has been suggested to act as an autocrine growth factor in chronic B cell malignancies. We have attempted to assess the role of TNFα in relation to the stage of chronic lymphocytic leukemia (CLL) by examining TNFα cytotoxic activity of media conditioned by stimulated and unstimulated peripheral blood mononuclear cells (PBMC) and by separated unstimulated malignant B cells from Rai stage 0 and IV patients. The response of PBMC from stage IV to stimulation with phytohemagglutinin, or bacterial lipopolysaccharide was weak or absent. However, stimulation of stage 0 PBMC induced significantly increased production of TNF. Furthermore, unstimulated stage 0 PBMC and B cells from these cases of stage 0 B CLL spontaneously released TNF in significant excess compared to normal PBMC controls while no TNF activity could be detected in supernatants from unstimulated stage IV PBMC or B cells. These data suggest a possible role for TNF in the progression of CLL. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

引用

页码：117 / 121

页数：5

共 19 条

[1]

Gale R.P., Foon K.A., Biology of chronic lymphocytic leukemia, Semin. Hematol, 24, pp. 209-229, (1987)

[2]

Rai K.R., Sawitzky A., Cronkite E.P., Clinical staging of chronic lymphocytic leukemia, Blood, 46, pp. 219-234, (1975)

[3]

Fernandez L.A., MacSween J.M., Langley G.R., Immunoregulation of B lymphocyte colony formation by T cell subsets in patients with chronic lymphocytic leukemia, Blood, 67, pp. 294-300, (1986)

[4]

Marcu K., Melchers F., Morse H.C., Potter M., Mechanisms in B cell neoplasia, Immunology Today, 7, (1986)

[5]

Matthews N., Production of an anti-tumor cytotoxin by human monocytes, Immunology, 44, pp. 135-142, (1981)

[6]

Dinarello C.A., An update on human interleukin-1: From molecular biology to clinical relevance, J. Clin. Immunol, 5, (1985)

[7]

Jelinek D.F., Lipsky P.E., Enhancement of human B cell proliferation and differentiation by TNFα and IL-1, J. Immunol, pp. 2970-2976, (1987)

[8]

Cordingley F.T., Bianchi A., Hoffbrand A.V., TNF as an autocrine tumor growth factor for chronic B cell malignancies, Lancet, II, pp. 969-971, (1988)

[9]

Morabito F., Prasthofer E.F., Dunlap N.E., Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce IL-1, Blood, 70, pp. 1750-1757, (1987)

[10]

Uggla C., Aguilar-Santelises M., Rosen A., Spontaneous production of IL-1 activity by chronic lymphocytic leukemia cells, Blood, 70, pp. 1851-1857, (1987)

← 1 2 →